NLRP3 and HIV-1 infection: The findings that cannabinoid treatment and CB2R activation are associated with reduced HIV-1 infection and inflammation and with reduced NLRP3 inflammasome signaling suggest a link between HIV-1 disease, CB2R receptor signaling, and NLRP3 inflammasome activation.